These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15979756)

  • 1. Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts.
    Song KH; Chung SJ; Shim CK
    J Control Release; 2005 Sep; 106(3):298-308. PubMed ID: 15979756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo preclinical evaluation of a minisphere emulsion-based formulation (SmPill®) of salmon calcitonin.
    Aguirre TA; Rosa M; Coulter IS; Brayden DJ
    Eur J Pharm Sci; 2015 Nov; 79():102-11. PubMed ID: 26349051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of proliposomes containing salmon calcitonin.
    Song KH; Chung SJ; Shim CK
    J Control Release; 2002 Nov; 84(1-2):27-37. PubMed ID: 12399165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage.
    Aguirre TAS; Aversa V; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
    J Control Release; 2016 Sep; 238():242-252. PubMed ID: 27480451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT).
    Sinko PJ; Lee YH; Makhey V; Leesman GD; Sutyak JP; Yu H; Perry B; Smith CL; Hu P; Wagner EJ; Falzone LM; McWhorter LT; Gilligan JP; Stern W
    Pharm Res; 1999 Apr; 16(4):527-33. PubMed ID: 10227707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable nanoparticles containing protein-fatty acid complexes for oral delivery of salmon calcitonin.
    Sang Yoo H; Gwan Park T
    J Pharm Sci; 2004 Feb; 93(2):488-95. PubMed ID: 14705204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride.
    du Plessis LH; Lubbe J; Strauss T; Kotzé AF
    Int J Pharm; 2010 Jan; 385(1-2):181-6. PubMed ID: 19854253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of salmon calcitonin (sCT) enteric-coated capsule for enhanced absorption and GI tolerability in rats.
    Wu L; Zhang G; Lu Q; Sun Q; Wang M; Li N; Gao Z; Sun Y; Li T; Han D; Yu X; Wang L; Sun W; Zhao D; Wu Y; Lu Y; Chen X
    Drug Dev Ind Pharm; 2010 Mar; 36(3):362-70. PubMed ID: 19719396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic absorption enhancement of salmon calcitonin and reversible mucosal injury by applying a mucolytic agent and a non-ionic surfactant.
    Takatsuka S; Morita T; Koguchi A; Horikiri Y; Yamahara H; Yoshino H
    Int J Pharm; 2006 Jun; 316(1-2):124-30. PubMed ID: 16600541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucoadhesive intestinal devices for oral delivery of salmon calcitonin.
    Gupta V; Hwang BH; Lee J; Anselmo AC; Doshi N; Mitragotri S
    J Control Release; 2013 Dec; 172(3):753-62. PubMed ID: 24035976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier.
    Li N; Li XR; Zhou YX; Li WJ; Zhao Y; Ma SJ; Li JW; Gao YJ; Liu Y; Wang XL; Yin DD
    Biomaterials; 2012 Dec; 33(34):8881-92. PubMed ID: 22975427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
    Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
    Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acylation of salmon calcitonin modulates in vitro intestinal peptide flux through membrane permeability enhancement.
    Trier S; Linderoth L; Bjerregaard S; Strauss HM; Rahbek UL; Andresen TL
    Eur J Pharm Biopharm; 2015 Oct; 96():329-37. PubMed ID: 26347924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine.
    Hiremath PS; Soppimath KS; Betageri GV
    Int J Pharm; 2009 Oct; 380(1-2):96-104. PubMed ID: 19616608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved intestinal delivery of salmon calcitonin by Lys18-amine specific PEGylation: stability, permeability, pharmacokinetic behavior and in vivo hypocalcemic efficacy.
    Youn YS; Jung JY; Oh SH; Yoo SD; Lee KC
    J Control Release; 2006 Sep; 114(3):334-42. PubMed ID: 16884808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
    Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
    J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine.
    Gupta V; Hwang BH; Doshi N; Mitragotri S
    J Control Release; 2013 Dec; 172(2):541-9. PubMed ID: 23680288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of the enhancing activity of glycyrrhizin on the intestinal absorption of drugs.
    Imai T; Sakai M; Ohtake H; Azuma H; Otagiri M
    Pharm Res; 1999 Jan; 16(1):80-6. PubMed ID: 9950283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.
    Liu L; Yang H; Lou Y; Wu JY; Miao J; Lu XY; Gao JQ
    Int J Pharm; 2019 Feb; 557():170-177. PubMed ID: 30597264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonic absorption of salmon calcitonin using tetradecyl maltoside (TDM) as a permeation enhancer.
    Petersen SB; Nielsen LG; Rahbek UL; Guldbrandt M; Brayden DJ
    Eur J Pharm Sci; 2013 Mar; 48(4-5):726-34. PubMed ID: 23354154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.